In that article the author says CTXI made a 'questionable' financing deal with Aspire. Huh? Sounds like he didn't understand the deal.

>>Cellceutix currently trades on the OTCBB. Stocks that trade OTC typically have high dilution concerns, questionable management, and liquidity concerns. All of these are true regarding Cellceutix. The company recently signed a questionable financing deal with Aspire Capital.<<

Seems like they just can't seem to gice a good word without folling up with two bad ones.

-bunny-